QT
CPRX

Quantbot Technologies’s Catalyst Pharmaceutical CPRX Stock Holding History

Quantbot Technologies’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Buy
56,560
+55,131
+3,858% +$1.63M 0.07% 395
2026
Q1 		$35.4K Buy
1,429
+548
+62% +$13.1K ﹤0.01% 1448
2025
Q4 		$20.6K Sell
881
-2,283
-72% -$50.9K ﹤0.01% 1566
2025
Q3 		$62.3K Sell
3,164
-14,739
-82% -$303K ﹤0.01% 1496
2025
Q2 		$388K Buy
17,903
+1,224
+7% +$28.9K 0.01% 1072
2025
Q1 		$404K Buy
16,679
+5,442
+48% +$123K 0.01% 955
2024
Q4 		$235K Buy
11,237
+3,636
+48% +$78.1K 0.01% 1021
2024
Q3 		$151K Buy
+7,601
New +$141K 0.01% 1080
2023
Q1 		– Sell
-25,300
Closed -$471K – 1626
2022
Q4 		$471K Sell
25,300
-47,746
-65% -$735K 0.03% 588
2022
Q3 		$937K Buy
+73,046
New +$866K 0.07% 404
2022
Q2 		– Sell
-7,500
Closed -$62K – 1759
2022
Q1 		$62K Buy
+7,500
New +$53K 0.01% 1151
2020
Q1 		– Sell
-800
Closed -$3K – 991
2019
Q4 		$3K Sell
800
-9,500
-92% -$44.4K ﹤0.01% 1143
2019
Q3 		$54K Buy
+10,300
New +$54.9K 0.01% 950

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quantbot Technologies's CPRX Position: Q2 2026 in Review

Quantbot Technologies increased its Catalyst Pharmaceutical (CPRX) stake by 3,858% in Q2 2026, buying an estimated $1.63M and bringing the position to 56,560 shares worth $1.78M. The position accounts for 0.07% of the portfolio, ranked #395.

Quantbot Technologies first reported a position in CPRX in Q3 2019 and has held it in 13 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Quantbot Technologies held 56,560 shares of Catalyst Pharmaceutical worth $1.78M as of Q2 2026.
  • Quantbot Technologies bought 55,131 Catalyst Pharmaceutical shares in Q2 2026, an estimated $1.63M.
  • Catalyst Pharmaceutical made up 0.07% of Quantbot Technologies's portfolio in Q2 2026, its #395 holding.
  • Quantbot Technologies first reported a position in Catalyst Pharmaceutical in Q3 2019 and has held it in 13 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.